Finshots

Something very ironic happened in the US recently. We all know how Trump imposed 25% tariffs on steel and aluminium imports; he also threatened similar imports on copper. But retaliatory tariffs from the EU, Canada, and China set off a trade war. And last week the US department of agriculture requested a few EU nations to export eggs to the US. Yes! You read that right. That's because the bird flu wiped out millions of hens causing egg shortage soaring the prices of eggs. The takeaway here is that we live in a deeply interconnected world where trade between countries and continents is indispensable. This also means that as much as tariffs act as a protective shield, they come at a cost. Take copper, for instance. Trump's proposed 25% tariff has already pushed prices past $10000 per tonne on the London Metal Exchange (LME), raising costs for industries like tech, construction, and renewable energy. History has shown that while tariffs aim to protect domestic industries, they often lead to unintended consequences, making goods more expensive and disrupting supply chains. What are your thoughts about tariffs' impact on the global and the Indian economy? Share with us in the comments below. Don't forget to follow Finshots for more such updates! Full story has been covered below, check it out! https://lnkd.in/gPJrNJd9

Ever wondered how much tax your favorite cricketers pay? Surprisingly, most of their earnings come from brand endorsements! Drop your thoughts below and follow Finshots for more!

Can Indian Pharma companies make cheaper alternatives to the weight-loss drug Ozempic? Last week, the American pharma giant Eli Lilly launched a new type of diabetes and weight-loss drug in India. Tirzepatide doesn’t just control blood sugar but also helps patients lose significant weight without extreme dieting. However, the cost of the drug is a hurdle. The injection is priced at ₹4,375 for a 5 mg vial and ₹3,500 for a 2.5 mg vial, its lowest doses. This means that a patient could spend over ₹2 lakh annually. And as these drugs often need to be taken long-term, affordability becomes a key issue. This is where Indian pharma companies come into the picture. With patents set to expire in 2026, Indian drugmakers are already working on more affordable alternatives. For instance, Glenmark Pharmaceuticals, recently launched Lirafit, a biosimilar of another GLP-1 drug, at 70% lower costs. So what do you think? Will these life-changing drugs be available to the masses? If yes, then will they be as effective at lower prices? We have covered the whole story for you over here- https://bit.ly/41WwY9v Check it out! Don’t forget to share your views with us below and tap on the follow button to not miss out on more valuable updates!

The Tata Group has retained the IPL title sponsorship rights for the 2024–2028 cycle by paying a whopping ₹2500 crore, with an annual payment of ₹500 crore! What are your thoughts on such a massive deal? Share this with your friends who would find it interesting and follow Finshots for more!

Do you want to be a millionaire? Do you want to retire before you are 40?🤔 If you want to do that you need to make sure you don’t lose your money to dubious scams in the stock market. And Abid Hassan from Sensibull is here to tell us all about them so you don’t fall for these traps✨ The most fun video of Finshots so far, please check it out. https://lnkd.in/gTsTCnxy

What could LIC entering the health insurance market look like? LIC is finally gearing up to enter the health insurance space most likely by buying stakes in an existing health insurance company (like ManipalCigna). However, it won’t be easy. LIC will first have to invest in experts who can design health-specific products, and set up infrastructure to manage high claim volumes and hospital relationships. Though one advantage would be LIC’s vast distribution network—14 lakh agents, 85 banks, 309 brokers, and more—could help drive health insurance penetration across India. But the competitors worry about cross-subsidization, meaning LIC could use a part of the profits earned from life insurance to subsidize health insurance premiums. And while consumers would love the cheaper pricing, it might trigger price war. Plus, investor confidence is at risk too. Because in 2016, life insurers in India were barred from selling indemnity-based health policies—these are the kind that directly cover hospital bills or medical costs through reimbursement or cashless facilities. So, reversing the policy might seem unfair to investors. What are your thoughts on LIC becoming a part of the health insurance space? We’ve got the full story covered below so check it out! https://bit.ly/4iHABqE Don’t forget to leave your views in the comments below and follow Finshots for more!

Petrol costs the highest in Andhra Pradesh and lowest in Andaman and Nicobar Islands. What factors according to you contribute to this price difference across states? Let us know in the comments below and follow Finshots for more!

Why is Coca-Cola not selling chips like PepsiCo? Coca-Cola and PepsiCo have been in a cola war for decades now. However, while PepsiCo has expanded into the snack market (like Lays and Kurkure), Coca-Cola has only focused on the beverage market. And surprisingly PepsiCo generates nearly 80% of its revenue from snacks. Coca-Cola seems to have missed out but the company has its reasons. Despite holding 60% of India’s carbonated drinks market, its FY24 profits dropped 40%, because of soaring marketing expenses. So instead of diversifying into snacks, it saw potential for deeper penetration in beverages. In 2023, it had only 41% urban and 32% rural household penetration. And with India’s non-alcoholic drinks market projected to grow to ₹1.47 lakh crore by 2030, Coca-Cola is expanding itself in a market where it is already a leader. But does this mean that Cola-Cola is not taking a shot at the snack market at all? Not exactly. Its recent partnership with Jubilant Bhartia Group, which operates Domino’s India, hints at a strategic move–perhaps securing beverage dominance in fast-food chains before making any snack-related moves. Will Coca-Cola take a bite of the snack market? What are your thoughts? We’ve got the full story covered for you below. Check it out and follow Finshots to not miss on more interesting updates! https://bit.ly/41EyxZJ

Only 11 companies from the original composition of Nifty 50 are still a part of it in 2025. What according to you sets them apart from the rest? Share this with your friends who would find it interesting. Let us know your thoughts in the comments and follow Finshots for more!

The watchdog ensuring the government spends your money right may not be truly independent. Here's what we mean– The Comptroller and Auditor General of India (CAG) is responsible for auditing government spending to ensure transparency and accountability. And it is important because the money the government spends, comes from taxpayers' pockets. Ensuring that it’s used properly is crucial. The CAG has done its job well by exposing major financial irregularities like the 2G spectrum, coal block allocation scam, etc. But here's the thing—the acronym CAG is used for both a person and an institution. And the CAG (person) is appointed by the President after consultation with the Prime Minister. Even though once appointed, CAG functions independently, it still raises concerns about partiality. Now, the Supreme Court has received a petition from the public interest litigation that the CAG should not be appointed by the ruling government. The Supreme Court in support accepted the plea. That’s because there have been incidents where crucial audits have been put on hold. For example, in Maharashtra, right before elections, a directive from the CAG’s headquarters suddenly paused all critical audits. Another instance—a National Project Audit, meant to review big infrastructure projects worth billions, was also put on hold without any official explanation. So is CAG’s independence being compromised? We’ve got the full story covered below. https://bit.ly/4bBEw64 Drop your views in the comments and follow Finshots for more!